Sample | Group (Ӏ)* | Group (ӀӀ)* | |||||||||||||
CaMV 35S | NOS | Ze in | β-globin | Cry1A.105 | Cry2Ab2 | Cry3Bb1 | CaMV 35S | NOS | Zein | β-globin | Cry1A.105 | Cry2Ab2 | Cry3Bb1 | ||
Negative control | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | |
Positive control | + | + | + | ‒ | + | + | + | + | + | + | ‒ | + | + | + | |
ZFEs, Group Ӏ | ‒ | ‒ | ‒ | + | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | + | ‒ | ‒ | ‒ | |
ZFEs, Group ӀӀ | ‒ | ‒ | ‒ | + | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | + | ‒ | ‒ | ‒ |